BIT
IMGN

BlackRock Institutional Trust’s Immunogen Inc IMGN Stock Holding History

BlackRock Institutional Trust’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.44M Buy
2,177,724
+50,044
+2% +$100K ﹤0.01% 2776
2016
Q3 		$5.7M Buy
2,127,680
+22,427
+1% +$65.2K ﹤0.01% 2639
2016
Q2 		$6.48M Sell
2,105,253
-18,791
-0.9% -$118K ﹤0.01% 2544
2016
Q1 		$18.1M Sell
2,124,044
-36,517
-2% -$309K ﹤0.01% 1888
2015
Q4 		$29.3M Buy
2,160,561
+108,187
+5% +$1.33M ﹤0.01% 1589
2015
Q3 		$19.7M Sell
2,052,374
-239,175
-10% -$3.5M ﹤0.01% 1853
2015
Q2 		$33M Sell
2,291,549
-141,339
-6% -$1.55M 0.01% 1570
2015
Q1 		$21.8M Buy
2,432,888
+8,215
+0.3% +$59.5K ﹤0.01% 1874
2014
Q4 		$14.8M Buy
2,424,673
+21,084
+0.9% +$193K ﹤0.01% 2103
2014
Q3 		$25.5M Sell
2,403,589
-40,460
-2% -$458K ﹤0.01% 1730
2014
Q2 		$29M Sell
2,444,049
-26,604
-1% -$334K ﹤0.01% 1704
2014
Q1 		$36.9M Buy
2,470,653
+122,432
+5% +$1.93M 0.01% 1529
2013
Q4 		$34.4M Buy
2,348,221
+11,611
+0.5% +$178K 0.01% 1529
2013
Q3 		$39.8M Sell
2,336,610
-77,995
-3% -$1.37M 0.01% 1352
2013
Q2 		$40.1M Buy
+2,414,605
New +$39.1M 0.01% 1290

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BlackRock Institutional Trust's IMGN Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Immunogen Inc (IMGN) stake by 2.4% in Q4 2016, buying an estimated $100K and bringing the position to 2,177,724 shares worth $4.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2776.

BlackRock Institutional Trust first reported a position in IMGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $40.1M in Q2 2013. 156 funds tracked by Wall St. Rank hold IMGN as of Q4 2016.

  • BlackRock Institutional Trust held 2,177,724 shares of Immunogen Inc worth $4.44M as of Q4 2016.
  • BlackRock Institutional Trust bought 50,044 Immunogen Inc shares in Q4 2016, an estimated $100K.
  • Immunogen Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2776 holding.
  • BlackRock Institutional Trust first reported a position in Immunogen Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Immunogen Inc position peaked at $40.1M in Q2 2013.
  • 156 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.